News

What sets Abstract apart is that the AI agents apply context for interpreting and predicting the impact of these changes, the ...
KalVista Pharmaceuticals, Inc. today announced that it will present new sebetralstat data at two upcoming congresses taking place concurrently from May 29?June 1, 2025: the 14th C1-inhibitor ...
The gallery will be exhibiting the artist's latest paintings, in which he has created a harmonious balance between minimalism ...
The stylishly high-concept but pleasingly no-frills New England rockers Perennial had a bit of a breakthrough with last ...
Discover how poorly made PowerPoint presentations waste millions in productivity, drain team focus, and increase business ...
About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting, taking place in New Orleans, May 13 through 17, 2025. The ...
Ontada researchers to present 14 data presentations at ISPOR 2025 including a podium presentation on distress thermometer screening in US oncology setting ...
Across his video and painting work, he deploys subtle and sophisticated shifts in tone, texture and surface, showing how the slightest change of light or angle can completely alter a work.
OSLO, Norway, April 29, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces four abstract presentations at the AUA 2025, highlighting the benefits of Blue Light ...
total) included carcinoma in-situ (CIS) (145; 43%), low-grade Ta (53; 16%), high -grade Ta (95; 28%), high-grade T1 (37; 11%), and high-grade T2 (5; 1%). As a are lacking. The authors developed ...